TY - JOUR
T1 - The Effect of Conditioned Media From Human Adipocyte-Derived Mesenchymal Stem Cells on Androgenetic Alopecia After Nonablative Fractional Laser Treatment
AU - Lee, Young In
AU - Kim, Jihee
AU - Kim, Jemin
AU - Park, Sujin
AU - Lee, Ju Hee
PY - 2020/12/1
Y1 - 2020/12/1
N2 - BACKGROUND: The conditioned media from adipocyte-derived mesenchymal stem cells-conditioned media (ADSC-CM) contains cytokines and growth factors that stimulate hair regeneration. OBJECTIVE: We evaluated the efficacy and safety of human ADSC-CM treatment on patients who underwent nonablative fractional laser for the treatment of androgenetic alopecia (AGA). MATERIALS AND METHODS: Thirty patients who underwent nonablative fractional laser treatment were topically administered either ADSC-CM or placebo solution. As a primary outcome, phototrichograms were taken to measure changes in hair density at each visit. In addition, global improvement scores (GISs) were compared by clinical digital photographs, which were taken at the initial and final visits, and assessed by 2 independent dermatologists. Finally, the investigator's improvement score was measured by questionnaire response during the final visit. RESULTS: Hair density comparisons during the treatment period revealed that the ADSC-CM group had significantly higher final densities compared with the placebo group. The GIS of the ADSC-CM group was also significantly higher than the placebo group. Finally, no adverse effects associated with the application of ADSC-CM were noted during the study. CONCLUSION: The application of ADSC-CM after nonablative fractional laser treatment accelerated increases in hair density and volume in AGA patients.
AB - BACKGROUND: The conditioned media from adipocyte-derived mesenchymal stem cells-conditioned media (ADSC-CM) contains cytokines and growth factors that stimulate hair regeneration. OBJECTIVE: We evaluated the efficacy and safety of human ADSC-CM treatment on patients who underwent nonablative fractional laser for the treatment of androgenetic alopecia (AGA). MATERIALS AND METHODS: Thirty patients who underwent nonablative fractional laser treatment were topically administered either ADSC-CM or placebo solution. As a primary outcome, phototrichograms were taken to measure changes in hair density at each visit. In addition, global improvement scores (GISs) were compared by clinical digital photographs, which were taken at the initial and final visits, and assessed by 2 independent dermatologists. Finally, the investigator's improvement score was measured by questionnaire response during the final visit. RESULTS: Hair density comparisons during the treatment period revealed that the ADSC-CM group had significantly higher final densities compared with the placebo group. The GIS of the ADSC-CM group was also significantly higher than the placebo group. Finally, no adverse effects associated with the application of ADSC-CM were noted during the study. CONCLUSION: The application of ADSC-CM after nonablative fractional laser treatment accelerated increases in hair density and volume in AGA patients.
UR - http://www.scopus.com/inward/record.url?scp=85097004190&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85097004190&partnerID=8YFLogxK
U2 - 10.1097/DSS.0000000000002518
DO - 10.1097/DSS.0000000000002518
M3 - Article
C2 - 32769526
AN - SCOPUS:85097004190
SN - 1076-0512
VL - 46
SP - 1698
EP - 1704
JO - Dermatologic Surgery
JF - Dermatologic Surgery
IS - 12
ER -